等待开盘 09-05 09:30:00 美东时间
-2.050
-4.82%
今日重点评级关注:BTIG:维持Climb Bio"买入"评级,目标价从20美元升至32美元;巴克莱:维持Alpha Tau Medical"超配"评级,目标价从17美元升至30美元
09-04 12:30
HC Wainwright & Co. analyst Emily Bodnar reiterates First Tracks (NASDAQ:TRAX) with a Buy and maintains $57 price target.
09-03 19:44
U.S. stocks were mostly higher, with the Dow Jones index gaining around 250 points on Wednesday. Shares of Sirius XM Holdings Inc (NASDAQ:SIRI) rose sharply during Wednesday’s session after Deutsche Bank upgraded the stock from Hold to Buy and raised its price target from $31 to $45. Sirius XM share...
09-02 22:26
今日重点评级关注:古根海姆:维持Scynexis"买入"评级,目标价从24美元升至33美元;韦德布什:维持Kura Oncology"跑赢大市"评级,目标价从36美元升至38美元
08-14 11:51
First Tracks Biotherapeutics Inc (NASDAQ:TRAX) reported a narrower loss for the second quarter on Wednesday. The company posted quarterly losses of 95 cents per share, versus losses of $1.47 per share in the year-ago period. “First Tracks continues to execute against a broad development strategy for...
08-13 21:07
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Truist Securities raised the price target for Andersen Group Inc (NYSE:ANDG) from $42 to $55. Truist Securitie...
08-13 19:41
First Tracks (NASDAQ:TRAX) reported quarterly losses of $(0.95) per share. This is a 35.37 percent increase over losses of $(1.47) per share from the same period last year.
08-13 04:38
今日重点评级关注:HC Wainwright & Co.:维持Innate Pharma"买入"评级,目标价从5美元升至7美元;HC Wainwright & Co.:维持Immix Biopharma"买入"评级,目标价从20美元升至25美元
08-11 11:45
UBS analyst Michael Yee maintains First Tracks (NASDAQ:TRAX) with a Buy and raises the price target from $45 to $65.
08-11 04:16
今日重点评级关注:HC Wainwright & Co.:维持Q32 Bio"买入"评级,目标价从13美元升至36美元;Chardan Capital:维持ProMIS Neurosciences"买入"评级,目标价从20美元升至33美元
07-29 11:37